CARDIZEM LA Drug Patent Profile

✉ Email this page to a colleague

When do Cardizem La patents expire, and when can generic versions of Cardizem La launch?

Cardizem La is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in CARDIZEM LA is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cardizem La

A generic version of CARDIZEM LA was approved as diltiazem hydrochloride by TEVA on May 31^st, 1995.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CARDIZEM LA?
What are the global sales for CARDIZEM LA?
What is Average Wholesale Price for CARDIZEM LA?

Summary for CARDIZEM LA

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	131
Clinical Trials:	10
Patent Applications:	2,870
Drug Prices:	Drug price information for CARDIZEM LA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CARDIZEM LA
What excipients (inactive ingredients) are in CARDIZEM LA?	CARDIZEM LA excipients list
DailyMed Link:	CARDIZEM LA at DailyMed

Drug patent expirations by year for CARDIZEM LA

Recent Clinical Trials for CARDIZEM LA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assiut University	Early Phase 1
CAMC Health System	Phase 4
University of South Florida	N/A

See all CARDIZEM LA clinical trials

Pharmacology for CARDIZEM LA

Drug Class	Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists

Paragraph IV (Patent) Challenges for CARDIZEM LA

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
CARDIZEM LA	Extended-release Tablets	diltiazem hydrochloride	120 mg, 180 mg, 240 mg, 300 mg and 360 mg	021392	1	2005-08-30
CARDIZEM LA	Extended-release Tablets	diltiazem hydrochloride	420 mg	021392	1	2005-04-25

US Patents and Regulatory Information for CARDIZEM LA

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-001	Feb 6, 2003	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-004	Feb 6, 2003	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-002	Feb 6, 2003	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CARDIZEM LA

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-001	Feb 6, 2003	⤷ Sign Up	⤷ Sign Up
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-003	Feb 6, 2003	⤷ Sign Up	⤷ Sign Up
Bausch	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-006	Feb 6, 2003	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CARDIZEM LA

See the table below for patents covering CARDIZEM LA around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	3725474		⤷ Sign Up
Australia	4903700		⤷ Sign Up
Canada	2348953	BILLES DE CIRE DE REMBOURRAGE POUR LA FABRICATION D'ARTICLESDE FORME SOLIDE (CUSHIONING WAX BEADS FOR MAKING SOLID SHAPED ARTICLES)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration